Mendowski S, Chapoutot P, Chesneau G, Ferlay A, Enjalbert F, Cantalapiedra Hijar G, et al. Effects of pretreatment with reducing sugars or an enzymatic cocktail before extrusion of fava bean on nitrogen metabolism and performance of dairy cows. J Dairy Sci. 2020;103:396-409 pubmed publisher

Soave M, Kellam B, Woolard J, Briddon S, Hill S. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization. SLAS Discov. 2020;25:186-194 pubmed publisher

Xie C, Wang Z, Zhang Y, Chen Y, Li R, Zhang J. Effect of Interaction between Adenosine and Nitric Oxide on Central Nervous System Oxygen Toxicity. Neurotox Res. 2019;36:193-203 pubmed publisher

Sehgal I, Dhooria S, Choudhary H, Aggarwal A, Garg M, Chakrabarti A, et al. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis. J Clin Microbiol. 2019;57: pubmed publisher

Martire A, Lambertucci C, Pepponi R, Ferrante A, Benati N, Buccioni M, et al. Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia. J Neurochem. 2019;149:211-230 pubmed publisher

Rivera Oliver M, Moreno E, Álvarez Bagnarol Y, Ayala Santiago C, Cruz Reyes N, Molina Castro G, et al. Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron. Mol Neurobiol. 2019;56:797-811 pubmed publisher

Shkhyan R, Lee S, Gullo F, Li L, Peleli M, Carlström M, et al. Genetic ablation of adenosine receptor A3 results in articular cartilage degeneration. J Mol Med (Berl). 2018;96:1049-1060 pubmed publisher

Liu G, Zhang W, Guo J, Kong F, Zhou S, Chen S, et al. Adenosine binds predominantly to adenosine receptor A1 subtype in astrocytes and mediates an immunosuppressive effect. Brain Res. 2018;1700:47-55 pubmed publisher

Odagaki Y, Kinoshita M, Ota T, Meana J, Callado L, Matsuoka I, et al. Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPγS) binding or [35S]GTPγS/immunoprecipitation assay. Purinergic Signal. 2018;14:177-190 pubmed publisher

Guarracino J, Cinalli A, Veggetti M, Losavio A. Endogenous purines modulate K+ -evoked ACh secretion at the mouse neuromuscular junction. J Neurosci Res. 2018;96:1066-1079 pubmed publisher

Mei H, Poonit N, Zhang Y, Ye C, Cai H, Yu C, et al. Activating adenosine A1 receptor accelerates PC12 cell injury via ADORA1/PKC/KATP pathway after intermittent hypoxia exposure. Mol Cell Biochem. 2018;446:161-170 pubmed publisher

Labazi H, Teng B, Mustafa S. Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice. Eur J Pharmacol. 2018;820:191-197 pubmed publisher

Soni H, Peixoto Neves D, Buddington R, Adebiyi A. Adenosine A1 receptor-operated calcium entry in renal afferent arterioles is dependent on postnatal maturation of TRPC3 channels. Am J Physiol Renal Physiol. 2017;313:F1216-F1222 pubmed publisher

Walker A, Sheffler D, Lewis A, Dickerson J, Foster D, Senter R, et al. Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory Reconsolidation. Neuropsychopharmacology. 2017;42:2553-2566 pubmed publisher

Zuccarini M, Giuliani P, Buccella S, Di Liberto V, Mudo G, Belluardo N, et al. Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells. Purinergic Signal. 2017;13:429-442 pubmed publisher

Riff R, Cohen Y, Eini Rider H, Naamani O, Mazar J, Haviv Y, et al. Systemic inflammatory response syndrome-related lymphopenia is associated with adenosine A1 receptor dysfunction. J Leukoc Biol. 2017;102:95-103 pubmed publisher

Jackson E, Zhang Y, Cheng D. Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine. Hypertension. 2017;69:484-493 pubmed publisher

Carlin J, Jain S, Gizewski E, Wan T, Tosh D, Xiao C, et al. Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology. 2017;114:101-113 pubmed publisher

Cheng P, Zuo X, Ren Y, Bai S, Tang W, Chen X, et al. Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion. Neurochem Res. 2016;41:3272-3277 pubmed

Vincenzi F, Ravani A, Pasquini S, Merighi S, Gessi S, Romagnoli R, et al. Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety. Neuropharmacology. 2016;111:283-292 pubmed publisher

Koszałka P, Gołuńska M, Urban A, Stasiłojć G, Stanisławowski M, Majewski M, et al. Specific Activation of A3, A2A and A1 Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration. PLoS ONE. 2016;11:e0151420 pubmed publisher

Almeida R, Comasseto D, Ramos D, Hansel G, Zimmer E, Loureiro S, et al. Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems. Mol Neurobiol. 2017;54:423-436 pubmed publisher

Searl T, Dynda D, Alanee S, El Zawahry A, McVary K, Silinsky E. A1 Adenosine Receptor-Mediated Inhibition of Parasympathetic Neuromuscular Transmission in Human and Murine Urinary Bladder. J Pharmacol Exp Ther. 2016;356:116-22 pubmed publisher

Romagnoli R, Baraldi P, Lopez Cara C, Cruz Lopez O, Moorman A, Massink A, et al. Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study. Eur J Med Chem. 2015;101:185-204 pubmed publisher

Santafe M, Priego M, Obis T, Garcia N, Tomas M, Lanuza M, et al. Adenosine receptors and muscarinic receptors cooperate in acetylcholine release modulation in the neuromuscular synapse. Eur J Neurosci. 2015;42:1775-87 pubmed publisher

Hughes S, Cravetchi X, Vilas G, Hammond J. Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281. Cell Signal. 2015;27:1008-18 pubmed publisher

Booker S, Pires N, Cobb S, Soares da Silva P, Vida I. Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors. Neuropharmacology. 2015;93:103-15 pubmed publisher

Zhang X, Xia J, Qian D, Wang Y, Lin Y, Huang X, et al. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway. Cardiology. 2014;129:153-62 pubmed publisher

Smith N, Bromley M, Denning D, Simpson A, Bowyer P. Elevated levels of the neutrophil chemoattractant pro-platelet basic protein in macrophages from individuals with chronic and allergic aspergillosis. J Infect Dis. 2015;211:651-60 pubmed publisher

Guo D, Venhorst S, Massink A, van Veldhoven J, Vauquelin G, Ijzerman A, et al. Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor. Br J Pharmacol. 2014;171:5295-312 pubmed publisher

Smith N, Hankinson J, Simpson A, Denning D, Bowyer P. Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in Chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT. Clin Microbiol Infect. 2014;20:O960-8 pubmed publisher

Gao X, Lu Q, Chou G, Wang Z, Pan R, Xia Y, et al. Norisoboldine attenuates inflammatory pain via the adenosine A1 receptor. Eur J Pain. 2014;18:939-48 pubmed publisher

Yang Z, Tian Y, Liu Y, Hennessy S, Kron I, French B. Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning. Oxid Med Cell Longev. 2013;2013:329183 pubmed publisher

Smith N, Hankinson J, Simpson A, Bowyer P, Denning D. A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosis. Clin Microbiol Infect. 2014;20:O480-8 pubmed publisher

Jackson E, Cheng D, Mi Z, Verrier J, Janesko Feldman K, Kochanek P. Role of CD73 in Renal Sympathetic Neurotransmission in the Mouse Kidney. Physiol Rep. 2013;1: pubmed

Kim J, Kim M, Ham A, Brown K, Greene R, D Agati V, et al. IL-11 is required for A1 adenosine receptor-mediated protection against ischemic AKI. J Am Soc Nephrol. 2013;24:1558-70 pubmed publisher

Langemeijer E, Verzijl D, Dekker S, IJzerman A. Functional selectivity of adenosine A1 receptor ligands?. Purinergic Signal. 2013;9:91-100 pubmed publisher

Crawford D, Jiang X, Taylor A, Mennerick S. Astrocyte-derived thrombospondins mediate the development of hippocampal presynaptic plasticity in vitro. J Neurosci. 2012;32:13100-10 pubmed

Hinze A, Mayer P, Harst A, von Kugelgen I. Adenosine A(3) receptor-induced proliferation of primary human coronary smooth muscle cells involving the induction of early growth response genes. J Mol Cell Cardiol. 2012;53:639-45 pubmed publisher

Tabor Godwin J, Tsueng G, Sayen M, Gottlieb R, Feuer R. The role of autophagy during coxsackievirus infection of neural progenitor and stem cells. Autophagy. 2012;8:938-53 pubmed publisher

Park S, Kim M, Kim J, Brown K, Haase V, D Agati V, et al. Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. Kidney Int. 2012;82:878-91 pubmed publisher

Hu S, Dong H, Zhang H, Wang S, Hou L, Chen S, et al. Noninvasive limb remote ischemic preconditioning contributes neuroprotective effects via activation of adenosine A1 receptor and redox status after transient focal cerebral ischemia in rats. Brain Res. 2012;1459:81-90 pubmed publisher

Prakasam H, Herrington H, Roppolo J, Jackson E, Apodaca G. Modulation of bladder function by luminal adenosine turnover and A1 receptor activation. Am J Physiol Renal Physiol. 2012;303:F279-92 pubmed publisher

Luca M, Liuni A, Muxel S, Munzel T, Forconi S, Gori T, et al. Chronic pharmacological preconditioning against ischemia. Clin Hemorheol Microcirc. 2011;49:287-93 pubmed publisher

Hamil N, Cock H, Walker M. Acute down-regulation of adenosine A(1) receptor activity in status epilepticus. Epilepsia. 2012;53:177-88 pubmed publisher

Komatsu S, Dobson J, Ikebe M, Shea L, Fenton R. Crosstalk between adenosine A1 and ?1-adrenergic receptors regulates translocation of PKC? in isolated rat cardiomyocytes. J Cell Physiol. 2012;227:3201-7 pubmed publisher

Dacho A, Lyutenski S, Aust G, Dietz A. Highly selective A(1) -adenosine-agonist (2-chloro-N6-cyclopentyladenosine) and reduction of flap necrosis in adipocutaneous flaps in rats. Head Neck. 2012;34:1100-5 pubmed publisher

Teng B, Mustafa S. A(2A) adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE-knockout mice. J Exp Pharmacol. 2011;2011:59-68 pubmed

Bott Flügel L, Bernshausen A, Schneider H, Luppa P, Zimmermann K, Albrecht Küpper B, et al. Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism. PLoS ONE. 2011;6:e18048 pubmed publisher

Littwitz C, Timpert M, Bender K, Pott L, Kienitz M. Autocrine signaling via A(1) adenosine receptors causes downregulation of M(2) receptors in adult rat atrial myocytes in vitro. Pflugers Arch. 2011;461:165-76 pubmed publisher

Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, et al. Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis. Eur J Pharmacol. 2011;650:639-49 pubmed publisher

Leshem Lev D, Hochhauser E, Chanyshev B, Isak A, Shainberg A. Adenosine A(1) and A (3) receptor agonists reduce hypoxic injury through the involvement of P38 MAPK. Mol Cell Biochem. 2010;345:153-60 pubmed publisher

Ponnoth D, Nadeem A, Tilley S, Mustafa S. Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. Am J Physiol Heart Circ Physiol. 2010;299:H81-7 pubmed publisher

Wong A, Guo C, Gupta R, Housley G, Thorne P, Vlajkovic S. Post exposure administration of A(1) adenosine receptor agonists attenuates noise-induced hearing loss. Hear Res. 2010;260:81-8 pubmed publisher

Yang Z, Sun W, Hu K. Adenosine A(1) receptors selectively target protein kinase C isoforms to the caveolin-rich plasma membrane in cardiac myocytes. Biochim Biophys Acta. 2009;1793:1868-75 pubmed publisher

Fukuda M, Suzuki Y, Hino H, Kuzume K, Morimoto T, Ishii E. Adenosine A1 receptor blockage mediates theophylline-associated seizures. Epilepsia. 2010;51:483-7 pubmed publisher

Pritchett C, Pardee A, McGuirk S, Will M. The role of nucleus accumbens adenosine-opioid interaction in mediating palatable food intake. Brain Res. 2010;1306:85-92 pubmed publisher

Bozarov A, Wang Y, Yu J, Wunderlich J, Hassanain H, Alhaj M, et al. Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1147-62 pubmed publisher

Xie C, Ran K, Liu J, Xu J, Chang Y. [Metallothionein mediates cardioprotection induced by delayed preconditioning with adenosine A1 receptor agonist in rabbits]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009;34:603-7 pubmed

Balakumar P, Singh H, Reddy K, Anand Srivastava M. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts. J Cardiovasc Pharmacol. 2009;54:204-12 pubmed publisher

Fenton R, Komatsu S, Ikebe M, Shea L, Dobson J. Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse. Am J Physiol Heart Circ Physiol. 2009;297:H718-25 pubmed publisher

Kang E, Vedantham K, Long X, Dadarlat M, Dadara M, Kwon I, et al. Drug-eluting stent for delivery of signal pathway-specific 1,3-dipropyl-8-cyclopentyl xanthine. Mol Pharm. 2009;6:1110-7 pubmed publisher

Gao Z, Ye K, Göblyös A, Ijzerman A, Jacobson K. Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. BMC Pharmacol. 2008;8:20 pubmed publisher

Narimatsu E, Niiya T, Kawamata M, Namiki A. Adenosine and adenosine uptake inhibitors potentiate the neuromuscular blocking action of rocuronium mediated by adenosine A(1) receptors in isolated rat diaphragms. Acta Anaesthesiol Scand. 2008;52:1415-22 pubmed publisher

Klutz A, Gao Z, Lloyd J, Shainberg A, Jacobson K. Enhanced A3 adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates. J Nanobiotechnology. 2008;6:12 pubmed publisher

Romagnoli R, Baraldi P, Carrion M, Cara C, Cruz Lopez O, Iaconinoto M, et al. Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor. J Med Chem. 2008;51:5875-9 pubmed publisher

Cappellacci L, Franchetti P, Vita P, Petrelli R, Lavecchia A, Jayaram H, et al. Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives. J Med Chem. 2008;51:4260-9 pubmed publisher

Jolly L, March J, Kemp P, Bennett T, Gardiner S. Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats. Br J Pharmacol. 2008;154:1600-10 pubmed publisher

Nakav S, Chaimovitz C, Sufaro Y, Lewis E, Shaked G, Czeiger D, et al. Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PLoS ONE. 2008;3:e2107 pubmed publisher

Cappellacci L, Franchetti P, Vita P, Petrelli R, Lavecchia A, Costa B, et al. 5'-Carbamoyl derivatives of 2'-C-methyl-purine nucleosides as selective A1 adenosine receptor agonists: affinity, efficacy, and selectivity for A1 receptor from different species. Bioorg Med Chem. 2008;16:336-53 pubmed

Deaglio S, Dwyer K, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204:1257-65 pubmed

Jacobson K, Gao Z, Tchilibon S, Duong H, Joshi B, Sonin D, et al. Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection. J Med Chem. 2005;48:8103-7 pubmed